Delivery Order SPE2DB20D3304-SPE2DB25FW9G4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,336.38 on September 18, 2025, for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5mL syringes. The contract carries a firm fixed price and is scheduled for completion by October 9, 2025. This non-set-aside award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ml syringes, with a ceiling value of $5,887.40. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $7,227.30 to supply Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. As a child contract, this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5mL syringes, with a contract ceiling value of $7,158.90 and a completion date of July 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,168.19 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and older, 0.5ml syringes), with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child order under the company's...
- The Defense Logistics Agency awarded a $2,605.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Spikevax 2025-26 vaccine syringes (6 months to 11 years, 0.25ML) to be delivered to the company's facility in Conshohocken, Pennsylvania by September 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW9G4Delivery Order
The Defense Logistics Agency awarded a $2,096.74 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger indefinite delivery contract vehicle, enabling the pharmaceutical distributor to supply medical commodities to support federal healthcare programs. This delivery order represents a routine transactional award under AmerisourceBergen Drug Corp's broader DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999.99 billion through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio includes vaccines, specialty medications, and medical supplies across multiple therapeutic domains, demonstrating its capability to meet competitive procurement requirements for the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/26/25 |